您当前的位置：
首页 >
文章列表页 >
Advances in population pharmacokinetics of meropenem in critically ill adult patients
更新时间：2025-11-25

    • Advances in population pharmacokinetics of meropenem in critically ill adult patients

    • “The treatment of severe infections with meropenem requires individualized administration at a dose of 500-1500mg, q4h to q6h, with priority given to prolonged infusion.”
    • ZHONGGUO YAOFANG   Vol. 36, Issue 22, Pages: 2873-2878(2025)

    • DOI：10.6039/j.issn.1001-0408.2025.22.21    

      CLC： R969.1

    • Received：29 July 2025，

      Revised：2025-10-31，

      Accepted：31 October 2025，

      Published：30 November 2025

    移动端阅览

  • XU Guiqin,DUO Delong,ZHAO Ni,et al.Advances in population pharmacokinetics of meropenem in critically ill adult patients[J].ZHONGGUO YAOFANG,2025,36(22):2873-2878. DOI： 10.6039/j.issn.1001-0408.2025.22.21.

  •  
  •  

0

Views

0

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

关于《抗菌药物临床应用指导原则》中几个问题的商榷

Related Author

邓一农 郭春霞 王 梅

Related Institution

No data
0